drugset / Trial / NCT02569437

Doxycycline in Treating Patients With Chronic Rhinosinusitis With Nasal Polyps

NCT02569437

Phase 2 Terminated 49 enrolled Icahn School of Medicine at Mount Sinai
RandomizedParallel-groupTriple-blindTreatment

Summary

The Department of Otolaryngology at Mount Sinai is looking for adults with sinus disease with polyps, otherwise called chronic rhinosinusitis with nasal polyps (CRSwNP). Patients may be eligible to enroll in a study offering a cutting-edge therapy to help reduce symptoms and avoid surgery. The treatment combines an antibiotic (doxycycline) with oral steroids. Oral steroids are the mainstay of medical management for patients with CRSwNP. However, recent studies have shown that doxycycline helps improve symptoms as well by reducing inflammation and killing common bacteria that can cause symptoms. This study is the first to evaluate this combination regimen.

Timeline

Start
2014-09
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline Small molecule 100 mg Oral
Background Fluticasone propionate Other / unclassified Intranasal
Background Methylprednisolone Other / unclassified 8 mg Oral

Indications